Log in
/
Register
Home
Overview
Upload / Manage Data
Browse / Search Studies
Analyze Studies
Tutorials
FAQ
Data Repository
Overview
Upload / Manage Studies
Browse / Search Studies
Analyze Studies
Data Sharing Policy
Tutorials
FAQ
Databases
Overview
Metabolite Database
Human Metabolome Gene/Protein Database (MGP)
RefMet: Reference List of Metabolite Names
External Metabolomics Databases (Links)
Protocols
Overview
General Protocols
Study-specific Protocols
Tools
Overview
Load and analyze your own dataset
Analyze Studies
MS Searches
Structure drawing
REST Service
External Tools (Links)
About
Overview
Publishing Partners
How to Cite
How to Link
Terms of Use
Personnel
Contact
Sitemap
Search
Keyword Search
Advanced Searches
Return to Statistics Toolbox
Pathway mapping for Study ST002922
(Analysis All analyses used)
Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1
Experimental factor
Group2
Treatment:Control (4)
Treatment:Control supernatant (4)
Treatment:DINCH 100nM (4)
Treatment:DINCH 100nM supernatant (4)
Treatment:DINCH 10nM (4)
Treatment:DINCH 10nM supernatant (4)
Treatment:DINCH 10µM (4)
Treatment:DINCH 10µM supernatant (4)
Treatment:DINCH 1µM (4)
Treatment:DINCH 1µM supernatant (4)
Treatment:Medium blank supernatant (3)
Treatment:MINCH 100nM (4)
Treatment:MINCH 100nM supernatant (4)
Treatment:MINCH 10nM (4)
Treatment:MINCH 10nM supernatant (4)
Treatment:MINCH 10µM (4)
Treatment:MINCH 10µM supernatant (4)
Treatment:MINCH 1µM (4)
Treatment:MINCH 1µM supernatant (4)
Treatment:MINCH GW supernatant (4)
Treatment:Rosiglitazone (4)
Treatment:Rosiglitazone supernatant (4)
Limit by pathway class:
Metabolic
Disease
Drug Action
Drug Metabolism
Physiological
Signaling
All
Analysis:
Reversed phase NEGATIVE ION MODE
Combine data for all analyses?:
Metabolomics Workbench
Terms of use
Site map
Contact